Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Jeffrey Olson

Concepts (319)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Vitreous Body
14
2020
104
3.050
 Why?
Ophthalmologic Surgical Procedures
5
2017
58
2.240
 Why?
Angiogenesis Inhibitors
11
2022
224
2.040
 Why?
Retina
11
2016
275
1.750
 Why?
Glaucoma
4
2017
216
1.650
 Why?
Alloys
4
2013
30
1.640
 Why?
Eye Foreign Bodies
5
2016
23
1.640
 Why?
Macular Edema
4
2022
37
1.590
 Why?
Retinal Detachment
6
2019
55
1.550
 Why?
Vitrectomy
7
2019
58
1.510
 Why?
Diabetic Retinopathy
6
2019
162
1.490
 Why?
Glaucoma Drainage Implants
3
2016
49
1.430
 Why?
Retinal Diseases
5
2017
81
1.280
 Why?
Intraocular Pressure
7
2017
290
1.260
 Why?
Nanopores
2
2020
4
1.240
 Why?
Intravitreal Injections
7
2022
46
1.220
 Why?
Membranes, Artificial
2
2020
79
1.190
 Why?
Nanotechnology
2
2020
121
1.120
 Why?
Suction
3
2015
33
1.040
 Why?
Choroidal Neovascularization
4
2011
45
0.980
 Why?
Sutures
3
2015
64
0.980
 Why?
Anterior Eye Segment
2
2017
10
0.970
 Why?
Swine
10
2017
786
0.940
 Why?
Suture Techniques
3
2015
137
0.940
 Why?
Equipment Design
6
2017
545
0.920
 Why?
Lens Implantation, Intraocular
2
2015
60
0.900
 Why?
Retinitis
1
2022
17
0.830
 Why?
Retinal Vasculitis
1
2022
7
0.830
 Why?
Aneurysm
1
2022
33
0.810
 Why?
Antibodies, Monoclonal
6
2020
1300
0.770
 Why?
Vitreoretinopathy, Proliferative
2
2019
12
0.760
 Why?
Vascular Endothelial Growth Factor A
6
2020
537
0.740
 Why?
Immunosuppressive Agents
3
2013
693
0.720
 Why?
Retinal Vessels
2
2015
54
0.720
 Why?
Durapatite
1
2020
55
0.710
 Why?
Cytomegalovirus Retinitis
2
2013
17
0.700
 Why?
Disease Models, Animal
8
2020
3823
0.700
 Why?
Complement System Proteins
2
2020
295
0.700
 Why?
Eye Injuries, Penetrating
3
2016
16
0.690
 Why?
Isoxazoles
2
2013
57
0.690
 Why?
Endophthalmitis
2
2017
25
0.690
 Why?
Scleral Buckling
3
2012
19
0.690
 Why?
Stents
2
2013
504
0.650
 Why?
Fluorocarbons
2
2012
106
0.600
 Why?
Anterior Chamber
1
2017
21
0.580
 Why?
Glucocorticoids
2
2020
554
0.580
 Why?
Transducers
1
2017
28
0.570
 Why?
Strabismus
1
2017
27
0.570
 Why?
Sclera
2
2015
37
0.550
 Why?
Filtering Surgery
1
2016
22
0.540
 Why?
Trabeculectomy
1
2017
71
0.530
 Why?
Surgical Instruments
2
2013
52
0.530
 Why?
Fovea Centralis
2
2006
8
0.530
 Why?
Ocular Hypertension
1
2016
61
0.520
 Why?
Laser Therapy
1
2017
106
0.510
 Why?
Retinal Perforations
2
2005
14
0.510
 Why?
Drug Resistance, Multiple, Viral
2
2013
11
0.510
 Why?
Ophthalmology
2
2013
78
0.510
 Why?
Lenses, Intraocular
1
2015
45
0.490
 Why?
Tomography, Optical Coherence
7
2015
136
0.490
 Why?
Lasers
1
2015
123
0.490
 Why?
Monitoring, Physiologic
1
2017
290
0.490
 Why?
Device Removal
1
2016
116
0.490
 Why?
Prostheses and Implants
1
2016
161
0.470
 Why?
Antiviral Agents
2
2013
673
0.470
 Why?
Fluorescein Angiography
9
2012
103
0.470
 Why?
Ischemia
2
2017
383
0.460
 Why?
Rabbits
3
2020
795
0.450
 Why?
Animals
18
2020
34345
0.440
 Why?
Models, Cardiovascular
1
2015
190
0.440
 Why?
Retinal Degeneration
2
2015
28
0.440
 Why?
Artificial Lens Implant Migration
1
2013
3
0.430
 Why?
Choroid
3
2015
47
0.430
 Why?
Macular Degeneration
6
2015
153
0.430
 Why?
Viscosupplements
1
2012
10
0.430
 Why?
Gravitation
1
2012
25
0.420
 Why?
Silicone Oils
1
2012
26
0.420
 Why?
Silicon
1
2012
15
0.420
 Why?
Pupil Disorders
1
2012
5
0.420
 Why?
Eye Enucleation
1
2012
10
0.410
 Why?
Viremia
1
2013
131
0.410
 Why?
Iris
1
2012
19
0.410
 Why?
Quantum Dots
1
2012
34
0.410
 Why?
Silicone Elastomers
1
2012
7
0.410
 Why?
Uveitis, Posterior
1
2012
12
0.400
 Why?
Surgical Stapling
1
2012
9
0.400
 Why?
Prosthesis Implantation
1
2013
149
0.400
 Why?
Fluocinolone Acetonide
1
2012
16
0.400
 Why?
Vitreous Hemorrhage
2
2015
6
0.390
 Why?
Cataract Extraction
1
2013
82
0.390
 Why?
Electric Stimulation Therapy
1
2012
75
0.390
 Why?
Vascular Endothelial Growth Factors
1
2011
68
0.380
 Why?
Models, Biological
4
2015
1753
0.380
 Why?
Materials Testing
1
2012
350
0.350
 Why?
Cytomegalovirus
2
2013
153
0.350
 Why?
Oxygen
1
2015
912
0.350
 Why?
Humans
47
2022
125132
0.340
 Why?
Anti-Inflammatory Agents
1
2012
471
0.310
 Why?
Interleukin 1 Receptor Antagonist Protein
1
2009
256
0.300
 Why?
Biocompatible Materials
1
2012
389
0.300
 Why?
Electroretinography
5
2016
41
0.290
 Why?
von Hippel-Lindau Disease
1
2007
12
0.280
 Why?
Antibodies, Monoclonal, Humanized
6
2015
666
0.280
 Why?
Pigment Epithelium of Eye
2
2006
34
0.280
 Why?
Injections
5
2012
171
0.280
 Why?
Drug Implants
2
2020
73
0.280
 Why?
Puerperal Disorders
1
2007
34
0.270
 Why?
Recombinant Fusion Proteins
4
2022
658
0.270
 Why?
Uveal Diseases
1
2006
5
0.270
 Why?
Ocular Hypotension
1
2006
11
0.270
 Why?
Fusobacterium Infections
1
2006
6
0.270
 Why?
Epiretinal Membrane
1
2005
6
0.260
 Why?
Pharyngeal Diseases
1
2006
17
0.260
 Why?
Visual Acuity
7
2019
282
0.260
 Why?
Ciliary Body
1
2006
34
0.260
 Why?
Needles
2
2017
60
0.260
 Why?
Dementia
2
2022
218
0.260
 Why?
Telangiectasis
1
2005
6
0.260
 Why?
Female
26
2022
64890
0.260
 Why?
Rats, Inbred BN
3
2011
54
0.250
 Why?
Uveitis
1
2006
117
0.250
 Why?
Receptors, Vascular Endothelial Growth Factor
3
2022
105
0.250
 Why?
Kidney Transplantation
2
2013
593
0.240
 Why?
Injections, Intraocular
2
2015
10
0.240
 Why?
Polypropylenes
2
2015
18
0.230
 Why?
Middle Aged
17
2019
29112
0.230
 Why?
Autoimmune Diseases
1
2006
406
0.210
 Why?
Laser Coagulation
3
2012
57
0.210
 Why?
Bevacizumab
6
2015
127
0.210
 Why?
Optic Atrophy
1
2022
11
0.210
 Why?
Hearing Loss, Central
1
2022
6
0.210
 Why?
Retinal Vein Occlusion
2
2015
13
0.190
 Why?
Rats
4
2012
5517
0.190
 Why?
Cell Count
2
2012
321
0.190
 Why?
Dialysis
1
2020
25
0.180
 Why?
Leukemia, Megakaryoblastic, Acute
1
2000
12
0.180
 Why?
Orbital Neoplasms
1
2000
21
0.180
 Why?
Male
21
2019
60793
0.180
 Why?
Adult
11
2022
33168
0.170
 Why?
Adsorption
1
2020
130
0.170
 Why?
Follow-Up Studies
5
2015
4824
0.170
 Why?
Time Factors
4
2017
6780
0.170
 Why?
Biomarkers
2
2020
3736
0.170
 Why?
Wet Macular Degeneration
1
2019
32
0.160
 Why?
Geographic Atrophy
1
2019
50
0.160
 Why?
Fluorescein-5-isothiocyanate
2
2009
39
0.160
 Why?
Eye Diseases, Hereditary
1
2018
14
0.150
 Why?
Miniaturization
2
2015
24
0.150
 Why?
Dextrans
2
2009
76
0.150
 Why?
Iris Diseases
1
2017
5
0.150
 Why?
Choroid Diseases
1
2017
9
0.140
 Why?
Glomerulonephritis, Membranoproliferative
1
1997
14
0.140
 Why?
Enzyme-Linked Immunosorbent Assay
1
2019
837
0.140
 Why?
Dark Adaptation
2
2012
13
0.140
 Why?
Hypertension
1
2006
1257
0.140
 Why?
Antimony
1
2016
5
0.140
 Why?
Infliximab
2
2007
93
0.140
 Why?
Aged, 80 and over
6
2019
6936
0.140
 Why?
Dose-Response Relationship, Drug
3
2014
2026
0.130
 Why?
Pressure
1
2017
237
0.130
 Why?
Polymers
1
2020
476
0.130
 Why?
Sclerostomy
1
2015
3
0.130
 Why?
Aged
10
2020
20859
0.130
 Why?
Treatment Outcome
9
2016
9790
0.130
 Why?
Foreign-Body Migration
1
2016
38
0.130
 Why?
Gyrate Atrophy
1
2015
2
0.130
 Why?
Vitreoretinal Surgery
1
2015
3
0.130
 Why?
Stress, Mechanical
1
2017
456
0.130
 Why?
Eye Infections, Bacterial
1
2015
25
0.130
 Why?
Health Knowledge, Attitudes, Practice
2
2014
1248
0.120
 Why?
Vitreous Detachment
1
2015
6
0.120
 Why?
Diagnostic Techniques, Ophthalmological
1
2015
35
0.120
 Why?
Partial Pressure
1
2015
35
0.120
 Why?
Equipment Failure Analysis
1
2015
142
0.120
 Why?
Hemoglobin SC Disease
1
2015
16
0.120
 Why?
Feedback
1
2015
157
0.120
 Why?
Biopsy, Needle
1
2015
191
0.120
 Why?
Prosthesis Failure
1
2016
119
0.120
 Why?
Down Syndrome
1
2000
403
0.120
 Why?
Oculomotor Muscles
1
2014
40
0.120
 Why?
Protein Binding
1
2020
2014
0.120
 Why?
International Normalized Ratio
1
2014
46
0.120
 Why?
Postoperative Care
1
2015
245
0.110
 Why?
Exchange Transfusion, Whole Blood
1
2013
16
0.110
 Why?
Diabetes Mellitus, Type 2
2
2012
2236
0.110
 Why?
Retinal Artery Occlusion
1
2013
8
0.110
 Why?
Warfarin
1
2014
146
0.110
 Why?
In Vitro Techniques
1
2015
1144
0.110
 Why?
Metabolomics
1
2018
551
0.110
 Why?
Tendons
1
2014
137
0.110
 Why?
Specific Gravity
1
2012
13
0.110
 Why?
Transducers, Pressure
1
2012
15
0.110
 Why?
Erythrocyte Transfusion
1
2015
207
0.110
 Why?
Adaptation, Ocular
1
2012
4
0.110
 Why?
Minerals
1
2012
39
0.110
 Why?
Research Design
1
2019
1035
0.100
 Why?
Rats, Mutant Strains
1
2012
24
0.100
 Why?
Viscosity
1
2012
91
0.100
 Why?
Antineoplastic Agents
2
2020
2009
0.100
 Why?
Pupil
1
2012
15
0.100
 Why?
Corneal Endothelial Cell Loss
1
2012
2
0.100
 Why?
Acetates
1
2012
104
0.100
 Why?
Retinal Neovascularization
1
2012
21
0.100
 Why?
Adolescent
4
2019
19411
0.100
 Why?
Endothelium, Corneal
1
2012
15
0.100
 Why?
Swine, Miniature
1
2012
73
0.100
 Why?
Sodium Chloride
1
2012
154
0.100
 Why?
Drug Combinations
1
2012
298
0.100
 Why?
Microsurgery
1
2012
64
0.100
 Why?
Electrodes, Implanted
1
2012
100
0.100
 Why?
Retinal Ganglion Cells
1
2012
92
0.100
 Why?
Tumor Necrosis Factor-alpha
2
2007
1198
0.100
 Why?
Bruch Membrane
1
2011
6
0.100
 Why?
Gold
1
2012
108
0.100
 Why?
Polyglycolic Acid
1
2011
40
0.090
 Why?
Administration, Oral
1
2013
785
0.090
 Why?
Drug Compounding
1
2011
91
0.090
 Why?
Registries
1
2019
2050
0.090
 Why?
Dissection
1
2011
56
0.090
 Why?
Delayed-Action Preparations
1
2011
163
0.090
 Why?
Anemia, Sickle Cell
1
2013
228
0.090
 Why?
Computer Simulation
1
2015
953
0.090
 Why?
Retrospective Studies
8
2015
13708
0.090
 Why?
Models, Animal
1
2012
373
0.090
 Why?
Atrial Fibrillation
1
2014
397
0.080
 Why?
Lactic Acid
1
2011
286
0.080
 Why?
Cell Survival
1
2012
1081
0.080
 Why?
Bacteria
1
2015
767
0.080
 Why?
Scotoma
1
2008
4
0.080
 Why?
Proliferating Cell Nuclear Antigen
1
2007
56
0.070
 Why?
Optic Neuropathy, Ischemic
1
2007
30
0.070
 Why?
Papilledema
1
2007
38
0.070
 Why?
Pilot Projects
1
2012
1530
0.070
 Why?
Severity of Illness Index
2
2014
2848
0.070
 Why?
Visual Fields
3
2007
79
0.070
 Why?
RNA, Catalytic
1
2007
183
0.070
 Why?
Retinitis Pigmentosa
1
2006
18
0.070
 Why?
Glycogen Storage Disease Type IIb
1
2006
22
0.070
 Why?
Triamcinolone Acetonide
1
2006
27
0.070
 Why?
Polyethylene Glycols
1
2011
577
0.070
 Why?
Fusobacterium necrophorum
1
2006
1
0.070
 Why?
Young Adult
2
2019
11385
0.070
 Why?
Indocyanine Green
1
2005
13
0.070
 Why?
Vision, Low
3
2013
14
0.070
 Why?
Myopia
1
2006
37
0.070
 Why?
Coloring Agents
1
2005
75
0.060
 Why?
Eye Injuries
1
2006
47
0.060
 Why?
Infusions, Intravenous
1
2006
391
0.060
 Why?
Staining and Labeling
1
2005
157
0.060
 Why?
Syndrome
1
2006
367
0.060
 Why?
Cataract
1
2006
200
0.050
 Why?
Multivariate Analysis
2
2019
1561
0.050
 Why?
Diagnosis, Differential
1
2007
1431
0.050
 Why?
Ranibizumab
2
2013
18
0.050
 Why?
Blindness
2
2013
37
0.050
 Why?
Postoperative Complications
1
2012
2325
0.050
 Why?
Keratitis
1
2000
13
0.040
 Why?
Exophthalmos
1
2000
16
0.040
 Why?
Chronic Disease
1
2006
1684
0.040
 Why?
Immunophenotyping
1
2000
286
0.040
 Why?
Tomography, X-Ray Computed
2
2016
2539
0.040
 Why?
Xanthine
1
2018
8
0.040
 Why?
Combined Modality Therapy
2
2013
1200
0.040
 Why?
Electrooculography
1
1997
11
0.040
 Why?
Visual Field Tests
1
1997
14
0.040
 Why?
Color Vision Defects
1
1997
6
0.040
 Why?
Fundus Oculi
1
1997
42
0.040
 Why?
Purines
1
2018
172
0.040
 Why?
Cohort Studies
2
2019
5348
0.030
 Why?
Child
2
2015
20014
0.030
 Why?
Photic Stimulation
1
1997
210
0.030
 Why?
Odds Ratio
1
2019
1050
0.030
 Why?
Vision Disorders
1
1997
136
0.030
 Why?
Microbiological Techniques
1
2015
32
0.030
 Why?
Myopia, Degenerative
1
2015
3
0.030
 Why?
Colony Count, Microbial
1
2015
124
0.030
 Why?
Endotamponade
1
2015
4
0.030
 Why?
Metabolome
1
2018
307
0.030
 Why?
Tenon Capsule
1
2014
3
0.030
 Why?
Tissue Adhesions
1
2015
32
0.030
 Why?
Mass Spectrometry
1
2018
699
0.030
 Why?
Disease Progression
2
2015
2577
0.030
 Why?
Pregnancy
1
2007
5922
0.030
 Why?
Photography
1
2015
98
0.030
 Why?
Atrophy
1
2015
166
0.030
 Why?
Biometry
1
2014
68
0.030
 Why?
Conjunctiva
1
2014
51
0.030
 Why?
Glucose
1
2018
995
0.030
 Why?
Risk Factors
2
2019
9549
0.030
 Why?
Fatty Acids, Omega-3
1
2014
125
0.030
 Why?
Retreatment
1
2012
72
0.030
 Why?
Risk Assessment
2
2014
3274
0.020
 Why?
Kaplan-Meier Estimate
1
2014
879
0.020
 Why?
Oxidative Stress
1
2018
1210
0.020
 Why?
Global Health
1
2014
350
0.020
 Why?
Proportional Hazards Models
1
2014
1191
0.020
 Why?
Survival Analysis
1
2014
1341
0.020
 Why?
Phenotype
1
2019
3153
0.020
 Why?
Health Care Costs
1
2014
415
0.020
 Why?
Antioxidants
1
2014
585
0.020
 Why?
Anticoagulants
1
2014
587
0.020
 Why?
Clinical Trials, Phase II as Topic
1
2009
58
0.020
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2014
420
0.020
 Why?
Clinical Trials, Phase I as Topic
1
2009
52
0.020
 Why?
Comorbidity
1
2014
1635
0.020
 Why?
Colorado
1
2019
4471
0.020
 Why?
Prospective Studies
2
2012
6818
0.020
 Why?
Retinal Artery
1
2007
16
0.020
 Why?
Cerebral Angiography
1
2007
117
0.020
 Why?
Infant
1
2000
8625
0.020
 Why?
Lysosomal-Associated Membrane Protein 2
1
2006
26
0.020
 Why?
Frameshift Mutation
1
2006
28
0.020
 Why?
Prognosis
1
2014
3616
0.020
 Why?
Anti-Bacterial Agents
1
2015
1559
0.020
 Why?
Secondary Prevention
1
2007
261
0.020
 Why?
Adrenal Cortex Hormones
1
2008
524
0.010
 Why?
Double-Blind Method
1
2007
1725
0.010
 Why?
RNA, Messenger
1
2007
2753
0.010
 Why?
Aging
1
2008
1706
0.010
 Why?
Olson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (319) concept(s)
_
Co-Authors Expand Description
See all (23) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)